Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Multi-Center Phase II Randomized Controlled Trial of Naïve T Cell Depletion for Prevention of Chronic Graft-Versus-Host Disease in Children and Young Adults

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03779854
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:11.861147+00:00
Published At
2025-10-15T00:00:00+00:00
Record Updated At
2025-10-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Biphenotypic Leukemia", "Acute Leukemia", "Acute Leukemia of Ambiguous Lineage", "Acute Lymphoblastic Leukemia", "Acute Undifferentiated Leukemia", "Allogeneic Hematopoietic Stem Cell Transplantation Recipient", "Blastic Plasmacytoid Dendritic Cell Neoplasm", "Blasts Under 25 Percent of Bone Marrow Nucleated Cells", "Blasts Under 5 Percent of Bone Marrow Nucleated Cells", "Mixed Phenotype Acute Leukemia", "Myelodysplastic Syndrome With Excess Blasts-1", "Myelodysplastic Syndrome/Acute Myeloid Leukemia", "Burkitt Leukemia", "Chronic Monocytic Leukemia", "Lymphoblastic Lymphoma", "Mast Cell Leukemia", "Myeloproliferative Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-10-15"
protocolSection.identificationModule.nctId
"NCT03779854"
protocolSection.identificationModule.officialTitle
"Multi-Center Phase II Randomized Controlled Trial of Na\u00efve T Cell Depletion for Prevention of Chronic Graft-Versus-Host Disease in Children and Young Adults"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Acute Biphenotypic Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Leukemia of Ambiguous Lineage (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Undifferentiated Leukemia (protocolSection.conditionsModule.conditions)
  • Allogeneic Hematopoietic Stem Cell Transplantation Recipient (protocolSection.conditionsModule.conditions)
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (protocolSection.conditionsModule.conditions)
  • Blasts Under 25 Percent of Bone Marrow Nucleated Cells (protocolSection.conditionsModule.conditions)
  • Blasts Under 5 Percent of Bone Marrow Nucleated Cells (protocolSection.conditionsModule.conditions)
  • Mixed Phenotype Acute Leukemia (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome With Excess Blasts-1 (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome/Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Burkitt Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Monocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • Mast Cell Leukemia (protocolSection.conditionsModule.conditions)
  • Myeloproliferative Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.